| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | PCYT1b |
| Uniprot No | P46020 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-1223aa |
| 氨基酸序列 | MRSRSNSGVRLDGYARLVQQTILCHQNPVTGLLPASYDQKDAWVRDNVYSILAVWGLGLAYRKNADRDEDKAKAYELEQSVVKLMRGLLHCMIRQVDKVESFKYSQSTKDSLHAKYNTKTCATVVGDDQWGHLQLDATSVYLLFLAQMTASGLHIIHSLDEVNFIQNLVFYIEAAYKTADFGIWERGDKTNQGISELNASSVGMAKAALEALDELDLFGVKGGPQSVIHVLADEVQHCQSILNSLLPRASTSKEVDASLLSVVSFPAFAVEDSQLVELTKQEIITKLQGRYGCCRFLRDGYKTPKEDPNRLYYEPAELKLFENIECEWPLFWTYFILDGVFSGNAEQVQEYKEALEAVLIKGKNGVPLLPELYSVPPDRVDEEYQNPHTVDRVPMGKLPHMWGQSLYILGSLMAEGFLAPGEIDPLNRRFSTVPKPDVVVQVSILAETEEIKTILKDKGIYVETIAEVYPIRVQPARILSHIYSSLGCNNRMKLSGRPYRHMGVLGTSKLYDIRKTIFTFTPQFIDQQQFYLALDNKMIVEMLRTDLSYLCSRWRMTGQPTITFPISHSMLDEDGTSLNSSILAALRKMQDGYFGGARVQTGKLSEFLTTSCCTHLSFMDPGPEGKLYSEDYDDNYDYLESGNWMNDYDSTSHARCGDEVARYLDHLLAHTAPHPKLAPTSQKGGLDRFQAAVQTTCDLMSLVTKAKELHVQNVHMYLPTKLFQASRPSFNLLDSPHPRQENQVPSVRVEIHLPRDQSGEVDFKALVLQLKETSSLQEQADILYMLYTMKGPDWNTELYNERSATVRELLTELYGKVGEIRHWGLIRYISGILRKKVEALDEACTDLLSHQKHLTVGLPPEPREKTISAPLPYEALTQLIDEASEGDMSISILTQEIMVYLAMYMRTQPGLFAEMFRLRIGLIIQVMATELAHSLRCSAEEATEGLMNLSPSAMKNLLHHILSGKEFGVERSVRPTDSNVSPAISIHEIGAVGATKTERTGIMQLKSEIKQVEFRRLSISAESQSPGTSMTPSSGSFPSAYDQQSSKDSRQGQWQRRRRLDGALNRVPVGFYQKVWKVLQKCHGLSVEGFVLPSSTTREMTPGEIKFSVHVESVLNRVPQPEYRQLLVEAILVLTMLADIEIHSIGSIIAVEKIVHIANDLFLQEQKTLGADDTMLAKDPASGICTLLYDSAPSGRFGTMTYLSKAAATYVQEFLPHSICAMQ |
| 预测分子量 | 137,3 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是3条关于PCYT1b重组蛋白的参考文献(信息基于公开研究整理，具体文献可能存在名称差异)：
1. **文献名称**: "Functional Characterization of Recombinant Human PCYT1B: A Key Enzyme in Phosphatidylcholine Biosynthesis"
**作者**: Smith J. et al.
**摘要**: 研究通过大肠杆菌表达系统成功纯化重组人源PCYT1b蛋白，证实其CTP:磷酸胆碱胞苷酰转移酶活性，并发现其酶活受脂质微环境调控，为磷脂代谢研究提供工具。
2. **文献名称**: "Structural Insights into PCYT1B Regulation by Phosphorylation"
**作者**: Lee S. & Kim D.
**摘要**: 利用昆虫细胞表达系统获得PCYT1b重组蛋白，通过晶体学解析其磷酸化修饰位点结构，揭示磷酸化如何通过构象变化调控酶活性，与代谢疾病相关突变位点关联。
3. **文献名称**: "PCYT1B Deficiency Disrupts Lipid Homeostasis: Recombinant Protein Rescue in Cellular Models"
**作者**: Garcia R. et al.
**摘要**: 构建PCYT1b缺陷细胞模型，外源添加重组PCYT1b蛋白可恢复磷脂酰胆碱合成并逆转内质网应激，证实其在脂质稳态中的关键作用及治疗潜力。
注：以上为模拟摘要，实际文献需通过PubMed/Google Scholar检索关键词“PCYT1B recombinant”“phosphorylated”等获取。
PCYT1B (Phosphate Cytidylyltransferase 1B), also known as CTP:phosphocholine cytidylyltransferase beta (CTβ), is a key regulatory enzyme in the Kennedy pathway responsible for phosphatidylcholine (PC) biosynthesis. This enzyme catalyzes the conversion of phosphocholine to CDP-choline, a rate-limiting step in the production of PC, an essential phospholipid critical for cell membrane structure, lipid signaling, and lipoprotein assembly. PCYT1B is one of two isoforms (alongside PCYT1A) encoded by distinct genes, with PCYT1B being predominantly expressed in tissues with high lipid turnover, including the liver, adipose tissue, and brain.
Dysregulation of PCYT1B has been linked to metabolic disorders, such as insulin resistance, non-alcoholic fatty liver disease (NAFLD), and impaired lipid homeostasis. Studies suggest that altered PCYT1B activity may influence membrane composition, lipid droplet dynamics, and very-low-density lipoprotein (VLDL) secretion. Its role in neuronal function and neurodegenerative diseases is also under investigation, given the importance of phospholipids in synaptic membranes and myelin sheaths.
Recombinant PCYT1B protein is produced using heterologous expression systems (e.g., E. coli, mammalian cells) to enable functional and structural studies. Purified recombinant PCYT1B facilitates enzymatic assays to characterize its kinetics, substrate specificity, and modulation by lipids or regulatory proteins. It is also used to explore interactions with therapeutic compounds, identify inhibitors/activators, and study post-translational modifications (e.g., phosphorylation) that regulate its activity. Structural analyses using recombinant protein help map catalytic domains and lipid-binding regions, providing insights into its membrane-associated activation mechanism. Additionally, recombinant PCYT1B serves as a tool to investigate disease-associated mutations and their impact on enzyme function, aiding the development of targeted therapies for metabolic and neurological disorders.
×
